|
|
News Breaks
|
October 28, 2011
|
| 04:56 EDT |  | MNOV |
| theflyonthewall.com: | MedicNova announces repeat dose clinical trial with MN-221 | | MediciNova announced initiation of a Phase 1b clinical trial with MN-221 in patients with stable, moderate-to-severe chronic obstructive pulmonary disease, or COPD, involving multiple administrations of intravenous MN-221 over several days in typical patients with concomitant illnesses. The trial is scheduled to commence enrollment by the end of the year.The clinical trial will be run under an existing Investigational New Drug, or IND, application for MN-221 and has completed FDA review. The main focus of the trial will be to test the safety of repeat administration over several days of MN-221 in patients suffering from moderate-to-severe COPD. Efficacy evaluation will include various respiratory parameters including forced expiratory volume in 1 second, or FEV1. :theflyonthewall.com |
|
|
News For MNOV From The Last 14 Days Check below for free stories on MNOV the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 23, 2012
|
| 16:03 EDT | | MNOV |
| | 16:01 EDT | | MNOV |
|
|
|
|
|
Subscribe for More Information